JENNIFER KAROUL: Open Payments
NPI 1407503865 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,315 in 103 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,505 · 2025 $2,315
Food & beverage: $2,315
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $459 |
| AstraZeneca Pharmaceuticals LP | 11 | $259 |
| Lilly USA, LLC | 13 | $238 |
| HARMONY BIOSCIENCES LLC | 2 | $169 |
| PFIZER INC. | 9 | $147 |
| Novo Nordisk Inc | 6 | $126 |
| Edwards Lifesciences Corporation | 3 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $78 |
| Exact Sciences Corporation | 3 | $78 |
| Amneal Pharmaceuticals LLC | 3 | $77 |
Products named: WAKIX, JARDIANCE, UBRELVY, VRAYLAR, PREVNAR 20, AIRSUPRA, ZEPBOUND, BREZTRI.
Industry payments across MA — which companies pay providers there.
